Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ljungcrantz

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1994
Prevention of trypsin-induced shock in rats by the pancreatic secretory trypsin inhibitorP Jönsson, I Ljungcrantz, K Ohlsson
Mediators of Inflammation|March 7, 2000
Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cellsM Nyström, M Bergenfeldt, I Ljungcrantz, et al.
Mediators of Inflammation|April 3, 2002
The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiationU Westin, M Nyström, I Ljungcrantz, et al.
Journal of Internal Medicine|September 12, 2008
Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodiesG N Fredrikson, H Björkbacka, I Söderberg, et al.
Journal of Internal Medicine|February 20, 2002
Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodiesA Gottsäter, J Forsblad, T Mätzsch, et al.
Journal of Internal Medicine|January 30, 2013
Association between CD8+ T-cell subsets and cardiovascular diseaseD Kolbus, I Ljungcrantz, L Andersson, et al.
Journal of Internal Medicine|December 1, 2010
Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccineM Wigren, D Kolbus, P Dunér, et al.
Journal of Internal Medicine|July 7, 2015
CD4+ CD56+ natural killer T-like cells secreting interferon-γ are associated with incident coronary eventsH Björkbacka, K E Berg, J Manjer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1994
Prevention of trypsin-induced shock in rats by the pancreatic secretory trypsin inhibitorP Jönsson, I Ljungcrantz, K Ohlsson
Mediators of Inflammation|March 7, 2000
Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cellsM Nyström, M Bergenfeldt, I Ljungcrantz, et al.
Mediators of Inflammation|April 3, 2002
The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiationU Westin, M Nyström, I Ljungcrantz, et al.
Journal of Internal Medicine|September 12, 2008
Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodiesG N Fredrikson, H Björkbacka, I Söderberg, et al.
Journal of Internal Medicine|February 20, 2002
Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodiesA Gottsäter, J Forsblad, T Mätzsch, et al.
Journal of Internal Medicine|January 30, 2013
Association between CD8+ T-cell subsets and cardiovascular diseaseD Kolbus, I Ljungcrantz, L Andersson, et al.
Journal of Internal Medicine|December 1, 2010
Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccineM Wigren, D Kolbus, P Dunér, et al.
Journal of Internal Medicine|July 7, 2015
CD4+ CD56+ natural killer T-like cells secreting interferon-γ are associated with incident coronary eventsH Björkbacka, K E Berg, J Manjer, et al.
Pageof 1